HBK Sorce Advisory LLC Takes $540,000 Position in HCA Healthcare, Inc. $HCA

HBK Sorce Advisory LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 1,267 shares of the company’s stock, valued at approximately $540,000.

Other institutional investors have also made changes to their positions in the company. Ameriflex Group Inc. bought a new position in HCA Healthcare in the second quarter valued at $27,000. Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. Clearstead Trust LLC raised its holdings in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $40,000. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Down 0.2%

Shares of HCA stock opened at $473.13 on Wednesday. The stock has a 50-day moving average of $477.30 and a 200-day moving average of $422.24. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The stock has a market cap of $107.96 billion, a price-to-earnings ratio of 18.29, a PEG ratio of 1.40 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period in the prior year, the firm earned $4.90 earnings per share. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HCA. Jefferies Financial Group upped their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Oppenheimer raised their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. TD Cowen upped their price objective on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Royal Bank Of Canada lifted their target price on HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a research note on Friday, December 19th. Finally, Robert W. Baird raised their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.